Difference between revisions of "DZI20-210-Case-5"
From MGH Learn Pathology
(Edited automatically from page DZI20-210.) |
(Automatic edit to upgrade to new templates) |
||
Line 1: | Line 1: | ||
− | {{ | + | {{ServiceRequestCase |
− | | | + | |identifier=DZI20-210-Case-5 |
− | | | + | |intent=order |
− | | | + | |category=409073007 |
− | | | + | |priority=routine |
− | | | + | |orderDetail=case |
− | | | + | |locationCode=learn |
− | | | + | |basedOn=DZI20-210 |
− | + | |code=faculty | |
− | + | |supportingInfo=Skin, right flank tumor: CD8+ tumor stage T-cell lymphoma. | |
− | | | ||
IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-. | IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-. | ||
+ | |reasonCode=86 yo man with tumor with ulceration for 3 months. (Guitart et al, Mod Path 30:761-72, 2017 , case #20) | ||
+ | |subject=public | ||
+ | |performer=Vn048 | ||
+ | |authoredOn=October 21, 2020 02:36:54 PM | ||
+ | |requester=Vn048 | ||
+ | |sequence=5 | ||
}} | }} | ||
− | {{ | + | {{Media |
− | | | + | |basedOn=DZI20-210-Case-5 |
− | | | + | |type=image |
− | | | + | |view=show |
− | | | + | |partOf=DZI20-210 |
− | + | |frames=1 | |
+ | |reasonCode=H&E | ||
+ | |identifier=DZI20-210-Case-5_1 | ||
+ | |createdDateTime=October 21, 2020 02:36:54 PM | ||
+ | |operator=Vn048 | ||
+ | |subject=Z0FBQUFBQmZrRWh6QlpYdGtnNGg1QUVfdXlEckV2UlVCZW9WMjJEY3RBSi0xd1ZzM2FGaDdaN203RFZzVDlpaWpEcE5CUkw3bGY0MEFwZ2hXS3l4Y0VtVTQ4U0Z6bXZLSnc9PQ | ||
+ | |modality=mrxs | ||
}} | }} |